Skip to main content
. 2016 May 3;353:i2231. doi: 10.1136/bmj.i2231

graphic file with name salf026084.f3_default.jpg

Fig 3 Forest plot showing risk of hypoglycaemia in patients treated with dipeptidyl peptidase-4 (DPP-4) inhibitors plus sulphonylureas compared with placebo plus sulphonylureas